AEMD
Price
$1.22
Change
+$0.05 (+4.27%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
4.4M
STE
Price
$232.52
Change
-$0.80 (-0.34%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
22.22B
33 days until earnings call
Interact to see
Advertisement

AEMD vs STE

Header iconAEMD vs STE Comparison
Open Charts AEMD vs STEBanner chart's image
Aethlon Medical
Price$1.22
Change+$0.05 (+4.27%)
Volume$1K
Capitalization4.4M
STERIS
Price$232.52
Change-$0.80 (-0.34%)
Volume$6.73K
Capitalization22.22B
AEMD vs STE Comparison Chart in %
Loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AEMD vs. STE commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a Buy and STE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (AEMD: $1.19 vs. STE: $232.57)
Brand notoriety: AEMD and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AEMD: 68% vs. STE: 96%
Market capitalization -- AEMD: $4.4M vs. STE: $22.22B
AEMD [@Medical Specialties] is valued at $4.4M. STE’s [@Medical Specialties] market capitalization is $22.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEMD’s FA Score shows that 1 FA rating(s) are green whileSTE’s FA Score has 1 green FA rating(s).

  • AEMD’s FA Score: 1 green, 4 red.
  • STE’s FA Score: 1 green, 4 red.
According to our system of comparison, STE is a better buy in the long-term than AEMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEMD’s TA Score shows that 3 TA indicator(s) are bullish while STE’s TA Score has 3 bullish TA indicator(s).

  • AEMD’s TA Score: 3 bullish, 3 bearish.
  • STE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AEMD is a better buy in the short-term than STE.

Price Growth

AEMD (@Medical Specialties) experienced а +0.85% price change this week, while STE (@Medical Specialties) price change was -4.16% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.52%. For the same industry, the average monthly price growth was +0.66%, and the average quarterly price growth was -0.00%.

Reported Earning Dates

AEMD is expected to report earnings on Jun 27, 2025.

STE is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Medical Specialties (+1.52% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) has a higher market cap than AEMD($4.4M). STE YTD gains are higher at: 13.699 vs. AEMD (-82.703). STE has higher annual earnings (EBITDA): 1.39B vs. AEMD (-12.28M). STE has more cash in the bank: 196M vs. AEMD (7.97M). AEMD has less debt than STE: AEMD (1.01M) vs STE (3.51B). STE has higher revenues than AEMD: STE (5.41B) vs AEMD (574K).
AEMDSTEAEMD / STE
Capitalization4.4M22.2B0%
EBITDA-12.28M1.39B-1%
Gain YTD-82.70313.699-604%
P/E RatioN/A38.85-
Revenue574K5.41B0%
Total Cash7.97M196M4%
Total Debt1.01M3.51B0%
FUNDAMENTALS RATINGS
AEMD vs STE: Fundamental Ratings
AEMD
STE
OUTLOOK RATING
1..100
798
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
10044
SMR RATING
1..100
9970
PRICE GROWTH RATING
1..100
9751
P/E GROWTH RATING
1..100
10061
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STE's Valuation (18) in the Medical Specialties industry is in the same range as AEMD (28). This means that STE’s stock grew similarly to AEMD’s over the last 12 months.

STE's Profit vs Risk Rating (44) in the Medical Specialties industry is somewhat better than the same rating for AEMD (100). This means that STE’s stock grew somewhat faster than AEMD’s over the last 12 months.

STE's SMR Rating (70) in the Medical Specialties industry is in the same range as AEMD (99). This means that STE’s stock grew similarly to AEMD’s over the last 12 months.

STE's Price Growth Rating (51) in the Medical Specialties industry is somewhat better than the same rating for AEMD (97). This means that STE’s stock grew somewhat faster than AEMD’s over the last 12 months.

STE's P/E Growth Rating (61) in the Medical Specialties industry is somewhat better than the same rating for AEMD (100). This means that STE’s stock grew somewhat faster than AEMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEMDSTE
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
N/A
Bearish Trend 6 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
57%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 2 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KDEF38.960.76
+1.99%
Plus Korea Defense Industry Index ETF
IDOG34.220.30
+0.89%
ALPS International Sector Div Dogs ETF
MFLX16.50-0.03
-0.18%
First Trust Flexible Muncpl Hgh Inc ETF
FUTY52.31-0.51
-0.97%
Fidelity MSCI Utilities ETF
DGP99.15-2.65
-2.60%
DB Gold Double Long ETN

AEMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, AEMD has been loosely correlated with ISPC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AEMD jumps, then ISPC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEMD
1D Price
Change %
AEMD100%
+1.71%
ISPC - AEMD
35%
Loosely correlated
+8.33%
GNGBY - AEMD
26%
Poorly correlated
+1.92%
IDXX - AEMD
25%
Poorly correlated
-1.23%
CSTL - AEMD
25%
Poorly correlated
+1.54%
HSDT - AEMD
24%
Poorly correlated
-5.71%
More